UNSPSC 51143023: Vinconate hydrochloride

This classification denotes a cholinergic agonist with the molecular formula C18H20N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H5MM0UO9N8, chemically known as vinconate hydrochloride, (+/-)-, but more generally known as vinconate hydrochloride, which bears US NIH Compound Identifier 147526. European Medicines Agency schedules vinconate hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00058MIG.

Most nations, for tariff purposes, schedule vinconate hydrochloride under HS 29339990. SMILES: CCN1CCC2C3CCCCC3N4C2C1CC=C4C(=O)OC.CL.

UNSPSC 51143023 Vinconate hydrochloride, a Commodity code, covers the procurement of this pharmaceutical compound by state and local health agencies, correctional departments, and medical facilities. Vinconate hydrochloride is a vinca alkaloid derivative used in oncology and hematology treatment protocols, typically acquired through pharmaceutical supply contracts or cooperative purchasing agreements that bundle multiple drugs and biologics. State and local buyers—primarily state health departments, county hospitals, state prison systems, and public university medical centers—source this drug either as a line item within broader pharmaceutical tenders or through standalone specialty-drug procurements when demand justifies dedicated purchasing activity.

No recent state and local contract opportunities under UNSPSC 51143023 appear in available procurement records as of July 2026. The lack of activity reflects both the specialized nature of the commodity—vinconate hydrochloride commands limited volume outside major academic medical centers and state oncology programs—and the likelihood that state and local buyers procure it as part of broader pharmaceutical supply agreements tagged at higher UNSPSC tiers (such as Family-level pharmaceutical codes) rather than at the individual-drug Commodity level. Buyers seeking this compound should monitor cooperative purchasing vehicles (such as GPOs or state-led pharmacy consortiums) and specialty-pharmaceutical RFPs issued by large integrated health systems, state Medicaid programs, or correctional health services rather than tracking this specific code for discrete solicitations.